In The Press
October, 2017
Alopexx completes first-in-man trial of its novel, broad- spectrum anti-microbial vaccine
September, 2017
Valerion Presents Preclinical Proof-of-Concept Data for VAL-0417 for the Treatment of Lafora Disease
August, 2017
Valerion: World Pharma Today
December, 2015
An Eye on Alzheimers
December, 2015
Alopexx Oncology Presents Encouraging Phase I/II Clinical Data On DI-Leu16-IL2 At The American Society Of Hematology Annual Meeting
September, 2015
Valerion Therapeutics Announces Positive Results Of Non-Clinical Research Study at SSIEM Annual Symposium
December, 2014
Cognoptix Expands Clinical Advisory Board
December, 2014
Catalent And Valerion Therapeutics Collaborate To Bring New Treatments For Orphan Genetic Disorders To Market
February, 2014
Cognoptix Eye Test Generates Robust Results in Clinical Study to Identify Alzheimer’s Disease
News/Corporate Highlights
April, 2013
MDA article on MTM program